Polivy 140 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9MC2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $52,298
Award facts
- Contract value 100% obligated
- $52,297.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $52,297.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 21, 2026, for the supply of Polivy 140 mg vials, with a completion date of February 11, 2026. This non-competitive delivery order will be performed at the awardee's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of a broad spectrum of pharmaceutical products and medical supplies to military healthcare programs worldwide. Polivy (polatuzumab vedotin) is a specialized oncology medication used in the treatment of B-cell lymphomas, reflecting the company's portfolio of specialty medications across multiple therapeutic domains delivered through the DLA's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F9MC2?
SPE2DR26F9MC2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26F9MC2 worth?
The government has obligated $52,298 on SPE2DR26F9MC2.
Is contract SPE2DR26F9MC2 an order under another contract?
Yes. SPE2DR26F9MC2 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9MC2 competed?
The extent of competition for SPE2DR26F9MC2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award